Article
- Author:
- Neil Osterweil
Publish date: January 22, 2021
Lockdown-related stress and psychological factors may play a role, but SARS-CoV-2 may also have still-unrecognized central nervous system effects.<...
News
- Author:
- Neil Osterweil
Publish date: January 20, 2021
Neither radiation nor docetaxel added to neoadjuvant cisplatin plus 5-fluorouracil increased the risk of perioperative complications when compared ...
News
- Author:
- Neil Osterweil
Publish date: January 20, 2021
Adding a tumor bed boost to whole breast irradiation cut the risk of local recurrence in half, regardless of fractionation.
News
- Author:
- Neil Osterweil
Publish date: January 19, 2021
In the absence of robust evidence, the joint guidelines outline key suggestions for clinical situations covering ...
News
- Author:
- Neil Osterweil
Publish date: January 19, 2021
Bemarituzumab improved progression-free and overall survival.
News
- Author:
- Neil Osterweil
Publish date: December 16, 2020
Patients with zero of four risk factors on the Burkitt Lymphoma International Prognostic Index had excellent 3-ye...
News
- Author:
- Neil Osterweil
Publish date: December 15, 2020
Fifteen of 16 patients with relapsed/refractory multiple myeloma had strong responses to therapy with BCMA- and C...
News
- Author:
- Neil Osterweil
Publish date: December 14, 2020
After an initial decline, quality of life measures rebounded for patients treated with atezolizumab or placebo plus chemotherapy.
News
- Author:
- Neil Osterweil
Publish date: December 10, 2020
The risk of relapse was more than fourfold higher for patients with DLBCL or Burkitt’s lymphoma treated at adult ...
News
- Author:
- Neil Osterweil
Publish date: December 10, 2020
Among participants in two iterations of the Nurses’ Health Study, healthier diets were linked to lower breast can...
News
- Author:
- Neil Osterweil
Publish date: December 9, 2020
Poorly controlled emotions and poor cognitive test scores were predictors for sickle cell disease pain-related ED...
News
- Author:
- Neil Osterweil
Publish date: December 7, 2020
An analysis of survivors showed higher levels of impairment across four domains, but the difference may be linked...
News
- Author:
- Neil Osterweil
Publish date: December 6, 2020
Seventy-two percent of patients with relapsed/refractory multiple myeloma had ongoing responses at the time of data cutoff in the CARTITUDE-1 trial...
News
- Author:
- Neil Osterweil
Publish date: November 25, 2020
A panel of reviewers highlighted abstracts from the digital edition of the 2020 Liver Meeting in the annual Clinical News Debrief.
News
- Author:
- Neil Osterweil
Publish date: November 20, 2020
Patients of White background had a nearly sixfold higher chance for functional cure of hepatitis B infection.
